INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 299 filers reported holding INTELLIA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 1.39 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $585,792 | -18.6% | 18,526 | +5.0% | 2.19% | -10.1% |
| Q2 2023 | $719,400 | +53.1% | 17,641 | +39.9% | 2.44% | +42.8% |
| Q1 2023 | $469,975 | +9.5% | 12,610 | +2.5% | 1.70% | +61.5% |
| Q4 2022 | $429,252 | -34.2% | 12,303 | +5.5% | 1.06% | -30.1% |
| Q3 2022 | $652,000 | +3.5% | 11,657 | -4.2% | 1.51% | +19.7% |
| Q2 2022 | $630,000 | -25.1% | 12,174 | +5.2% | 1.26% | +13.6% |
| Q1 2022 | $841,000 | +8.5% | 11,575 | +76.6% | 1.11% | +23.9% |
| Q4 2021 | $775,000 | – | 6,555 | – | 0.90% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,216,340 | $62,958,000 | 7.04% |
| Discovery Value Fund | 584,483 | $30,253,000 | 6.33% |
| MPM BioImpact LLC | 299,409 | $15,497,000 | 4.30% |
| ARK Investment Management | 9,514,580 | $439,003,000 | 2.60% |
| Elmwood Wealth Management, Inc. | 67,899 | $3,514,000 | 2.00% |
| Nikko Asset Management Americas, Inc. | 2,781,136 | $141,143,000 | 1.74% |
| Avidity Partners Management LP | 1,125,194 | $58,240,000 | 1.34% |
| Merlin Capital, Inc | 12,174 | $630,000 | 1.26% |
| Atlas Venture Associates IX, LLC | 10,000 | $518,000 | 1.18% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $5,768,000 | 1.16% |